Predictions
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€69.50
29.04.24
29.04.24
€100.00
31.03.26
31.03.26
-0.75%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.73
25.04.24
25.04.24
-
25.04.25
25.04.25
0.80%
27.04.24
27.04.24
Risky Investment
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.60
25.04.24
25.04.24
-
25.04.25
25.04.25
-2.00%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Fibrogen Inc.
Start price
Target price
Perf. (%)
€1.07
19.04.24
19.04.24
-
19.04.25
19.04.25
-10.90%
28.04.24
28.04.24
Could be very worthwhile Investment >20% year
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.75
15.04.24
15.04.24
€3.00
31.10.25
31.10.25
-
15.04.24
15.04.24
Could be very worthwhile Investment >20% year
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€1.66
14.04.24
14.04.24
-
14.04.25
14.04.25
-13.86%
28.04.24
28.04.24
Could be worthwhile Investment >10% per year
Inotiv Inc.
Start price
Target price
Perf. (%)
€5.50
13.04.24
13.04.24
€4.00
13.04.25
13.04.25
-32.36%
27.04.24
27.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Nektar Therapeutics
Start price
Target price
Perf. (%)
€1.50
11.04.24
11.04.24
-
11.04.25
11.04.25
3.27%
14.04.24
14.04.24
Risky Investment
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€66.50
07.04.24
07.04.24
-
07.04.25
07.04.25
0.75%
14.04.24
14.04.24
Could be very worthwhile Investment >20% year
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.11
02.04.24
02.04.24
-
02.04.25
02.04.25
-38.74%
16.04.24
16.04.24
Could be very worthwhile Investment >20% year
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.14
02.04.24
02.04.24
-
02.04.25
02.04.25
-28.14%
13.04.24
13.04.24
Could be worthwhile Investment >10% per year
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.60
02.04.24
02.04.24
-
02.04.25
02.04.25
-48.88%
13.04.24
13.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€2.64
28.03.24
28.03.24
-
28.03.25
28.03.25
-40.27%
31.03.24
31.03.24
Risky Investment
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€2.55
28.03.24
28.03.24
-
28.03.25
28.03.25
-38.27%
30.03.24
30.03.24
Could be worthwhile Investment >10% per year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.88
26.03.24
26.03.24
-
26.03.25
26.03.25
-18.09%
31.03.24
31.03.24
Risky Investment
SELLAS Life Sciences Group Inc
Start price
Target price
Perf. (%)
€1.06
26.03.24
26.03.24
-
26.03.25
26.03.25
-1.69%
31.03.24
31.03.24
Risky Investment
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€2.57
21.03.24
21.03.24
-
21.03.25
21.03.25
-38.64%
31.03.24
31.03.24
Could be very worthwhile Investment >20% year
Fibrogen Inc.
Start price
Target price
Perf. (%)
€2.22
21.03.24
21.03.24
-
21.03.25
21.03.25
2.97%
29.03.24
29.03.24
Probably not worthwhile Investment
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
18.03.24
18.03.24
-
18.03.25
18.03.25
2.26%
30.03.24
30.03.24
Could be worthwhile Investment >10% per year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
17.03.24
17.03.24
€0.30
30.11.25
30.11.25
76.96%
28.03.24
28.03.24
Could be very worthwhile Investment >20% year
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€5.80
17.03.24
17.03.24
€3.00
31.01.26
31.01.26
60.34%
25.03.24
25.03.24
Could be very worthwhile Investment >20% year
Verastem Inc.
Start price
Target price
Perf. (%)
€10.20
17.03.24
17.03.24
€16.00
30.06.26
30.06.26
-8.82%
19.03.24
19.03.24
Could be very worthwhile Investment >20% year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
16.03.24
16.03.24
€2.00
16.03.25
16.03.25
2.26%
30.03.24
30.03.24
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Chromadex Corp
Start price
Target price
Perf. (%)
€2.22
16.03.24
16.03.24
€4.00
16.03.25
16.03.25
53.15%
30.03.24
30.03.24
EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€4.89
16.03.24
16.03.24
€48.00
16.03.25
16.03.25
-12.06%
30.03.24
30.03.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected